Dr. Winnie Mpanju-Shumbusho

• 
  www.iapac.org/home.asp?pid=210 - [Cached Version]
  Published on: 7/10/2002    Last Visited: 3/6/2007  

  Winnie Mpanju Shumbusho of the WHO affirmed support of both initiatives."What has been lacking in the HIV/AIDS map, and what has been echoing from the field is the ‘How-to,'" she said."Those of us who have worked in resource-poor areas realize the power of relatively simple initiatives to make a real difference in the lives of the people who show up at our clinics day in and day out."In tandem, these initiatives promise to enable physicians to provide the best possible care to HIV-infected patients within the realities of their particular settings, she said.

• 
  www.baniya.com/cgi-bin/baniya/fit_news.pl - [Cached Version]
  Published on: 2/27/2001    Last Visited: 12/25/2001  

  A number of available regimens are known to be effective and safe, said Dr. Winnie Mpanju Shumbusho, Director of the HIV/AIDS/STI initiative of WHO.The choice should be determined according to local circumstances on the grounds of cost and practicality, particularly as related to the availability and quality of antenatal care.
  
  The safety of preventive treatments including zidovuding alone, zidovudine and lamivudine, and nevirapine, has been studied extensively for both breast feeding and non-breastfeeding populations worldwide.Information currently does not suggest any adverse effects on the health of the mother, growth and development of infants, or the health and mortality of infants infected despite prophylaxis.
  
  The most complex regimen includes antepartum and intrapartum zidovudine for the mother and post-natal doses for the infant.

• 
  AIDS Therapies: Prevention of Mother-to-Child HIV... - [Cached Version]
  Published on: 12/18/2000    Last Visited: 2/12/2002  

  "A number of available regimens are known to be effective and safe," said Dr. Winnie Mpanju-Shumbusho, director of the HIV/AIDS/STI Initiative of the World Health Organization."The choice should be determined according to local circumstances on the grounds of costs and practicality, particularly as related to the availability and quality of antenatal care."
  
  The safety of preventive treatments including zidovudine alone, zidovudine and lamivudine, and nevirapine, has been studied extensively for both breastfeeding and non-breastfeeding populations worldwide.Information currently available does not suggest any adverse effects on the health of the mother, growth and development of infants, or the health and mortality of infants infected despite prophylaxis.
  
  The most complex regimen includes antepartum and intrapartum zidovudine for the mother and postnatal doses for the infant.

• 
  BostonHerald.com - So much for another fundamentalist... - [Cached Version]
  Published on: 11/26/2004    Last Visited: 11/26/2004  

  Globally, only about 440,000 AIDS patients in developing countries were fortunate enough to be getting the coveted antiretroviral drug regimens by June of this year, according to Dr. Winnie Mpanju-Shumbusho of the World Health Organization, who attended Sunday's gathering.
  ...
  Globally, only about 440,000 AIDS patients in developing countries were fortunate enough to be getting the coveted antiretroviral drug regimens by June of this year, according to Dr. Winnie Mpanju-Shumbusho of the World Health Organization, who attended Sunday's gathering.

• 
  Contact - Board - About the Global Fund - The Global... - [Cached Version]
  Published on: 9/3/2008    Last Visited: 9/3/2008  

  Dr. Winnie Mpanju-ShumbushoSenior Adviser to the Assistant Director General

• 
  Delegations - Board - Core Structures - Who We Are -... - [Cached Version]
  Published on: 4/8/2009    Last Visited: 4/8/2009  

  Dr. Winnie Mpanju-Shumbusho Senior Adviser to the Assistant Director General

• 
  Features - Bookmarks - [Cached Version]
  Published on: 10/1/2000    Last Visited: 3/10/2006  

  "A number of available regimens are known to be effective and safe," said Dr Winnie Mpanju-Shumbusho, Director of the HIV/AIDS/STI Initiative of WHO.

• 
  News: 25 October 2000: Preventing Mother-to-Child HIV... - [Cached Version]
  Published on: 10/25/2000    Last Visited: 5/4/2002  

  "A number of available regimens are known to be effective and safe," said Dr Winnie Mpanju-Shumbusho, Director of the HIV/AIDS/STI Initiative of WHO."The choice should be determined according to local circumstances on the grounds of costs and practicality, particularly as related to the availability and quality of antenatal care."
  
  The safety of preventive treatments including zidovudine alone, zidovudine and lamivudine, and nevirapine, has been studied extensively for both breastfeeding and non-breastfeeding populations worldwide.Information currently available does not suggest any adverse effects on the health of the mother, growth and development of infants, or the health and mortality of infants infected despite prophylaxis.
  
  The most complex regimen includes antepartum and intrapartum zidovudine for the mother and post-natal doses for the infant.

• 
  September 2001; No. 2: NGOs condemn U.S. delegation's... - [Cached Version]
  Published on: 9/1/2001    Last Visited: 7/16/2006  

  Dr. Winnie Mpanju-Shumbusho, Director for HIV/AIDS Strategy, Advocacy and Partnership under the World Health Organisation (WHO), cited poverty as one of the main reasons for the spread of HIV/AIDS in the developing countries.

• 
  September 2001; No. 2: NGOs condemn U.S. delegation's... - [Cached Version]
  Published on: 9/1/2001    Last Visited: 5/25/2005  

  Dr. Winnie Mpanju-Shumbusho, Director for HIV/AIDS Strategy, Advocacy and Partnership under the World Health Organisation (WHO), cited poverty as one of the main reasons for the spread of HIV/AIDS in the developing countries.

Page:  1 2